You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vinorelbine

Showing 26 - 50 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Besançon (Letrozole, Anastrozole, Vinorelbine)

Terminated
  • Breast Cancer
  • Besançon, France
    CHU Besançon
Jan 29, 2021

NSCLC, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA Trial (biological, drug, other)

Withdrawn
  • Non-Small Cell Lung Cancer
  • +2 more
  • Nivolumab
  • +8 more
  • (no location specified)
Mar 9, 2022

Multiple Myeloma Trial in Berne (Vinorelbine, Gemcitabine, G-CSF)

Recruiting
  • Multiple Myeloma
  • Vinorelbine
  • +2 more
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,

No longer available
  • Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
  • Triple-Negative Breast Cancer
  • Seattle, Washington
    Seattle Cancer Care Allliance
Jul 14, 2021

Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)

Completed
Has Results
  • Pleural Mesothelioma Malignant Advanced
  • Barcelona, Spain
  • +14 more
Aug 23, 2022

Advanced Breast Cancer Trial in Milan (Vinorelbine, Capecitabine, Cyclophosphamide)

Unknown status
  • Advanced Breast Cancer
  • Vinorelbine
  • +2 more
  • Milan, Italy
    European Institute of Oncology
Apr 24, 2020

Aggressive Non-Hodgkin Lymphoma Trial in Italy (Prednisone, Vinorelbine, Etoposide)

Completed
  • Aggressive Non-Hodgkin Lymphoma
  • Brescia, Italy
  • +9 more
Dec 17, 2021

Head and Neck Tumors Trial in Odense (Cetuximab, Carboplatin, Vinorelbine)

Withdrawn
  • Head and Neck Neoplasms
  • Odense, Denmark
    Department of Oncology, Odense University Hospital
Oct 29, 2020

Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Carcinoma
  • +3 more
  • Palo Alto, California
  • +9 more
May 12, 2022

Diffuse Intrinsic Pontine Glioma Trial in Milan (Nimotuzumab, Vinorelbine, Radiotherapy)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Breast Cancer Trial in Shanghai (Vinorelbine, Capecitabine)

Unknown status
  • Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Mar 7, 2020

Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 17, 2020

HER2-expressing Cancers Trial in Canada, Korea, Republic of, United States (ZW25 (Zanidatamab), Paclitaxel, Capecitabine)

Active, not recruiting
  • HER2-expressing Cancers
  • ZW25 (Zanidatamab)
  • +4 more
  • Birmingham, Alabama
  • +16 more
Feb 25, 2022

Breast Cancer Trial in Shanghai (Capecitabine, Vinorelbine)

Unknown status
  • Breast Cancer
  • Shanghai, Shanghai, China
    Cancer Hospital/ Institute, Fudan University
Mar 11, 2020

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Breast Cancer Trial in Shanghai (Vinorelbine, Capecitabine, Trastuzumab)

Unknown status
  • Breast Cancer
  • Vinorelbine
  • +2 more
  • Shanghai, China
    Zhi-Ming Shao
Mar 3, 2020

Breast Cancer Trial in Guangzhou (Inetetamab, Pyrotinib, Capecitabine)

Recruiting
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun Yat Sen Memorial Hospital，Sun Yat sen University
Dec 18, 2020

Diffuse Large B-cell Lymphoma Trial in ZhengZhou (Chidamide, Vinorelbine, Liposomal Doxorubicin or mitoxantrone)

Unknown status
  • Diffuse Large B-cell Lymphoma
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 31, 2020

Metronomic Oral Vinorelbine in Elderly Locally Advanced /

Unknown status
  • Locally Advanced/ Metastatic NSCLC
  • Vinorelbine
  • Pesaro, Yes, Italy
    Azienda Ospedaliera Ospedali Riuniti Marche Nord
Dec 23, 2019

Primary Breast Cancer Trial in Beijing (Vinorelbine)

Recruiting
  • Primary Breast Cancer
  • Vinorelbine
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Oct 26, 2020

Metastatic Breast Cancer Trial (Vinorelbine, Gemcitabine, Carboplatin)

Not yet recruiting
  • Metastatic Breast Cancer
  • Vinorelbine
  • +2 more
  • (no location specified)
Oct 27, 2019

Lung Cancer Trial in Spain (Vinorelbine, Cisplatin, Radiotherapy)

Completed
  • Lung Cancer
  • Vinorelbine
  • +2 more
  • Elche, Alicante, Spain
  • +17 more
Jan 8, 2020

Advanced Breast Cancer, HER2-positive Breast Cancer Trial in Freiburg (Trastuzumab, Pertuzumab, Vinorelbine)

Withdrawn
  • Advanced Breast Cancer
  • HER2-positive Breast Cancer
  • Freiburg, Baden-Wuerttemberg, Germany
    iOMEDICO AG
Nov 25, 2019

Breast Cancer Trial in Worldwide (Dato-DXd, Capecitabine, Gemcitabine)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +172 more
Dec 1, 2022

Mesothelioma Trial in Worldwide (Anetumab ravtansine (BAY94-9343), Vinorelbine)

Completed
Has Results
  • Mesothelioma
  • Anetumab ravtansine (BAY94-9343)
  • Vinorelbine
  • La Jolla, California
  • +74 more
Oct 28, 2020